BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26255735)

  • 21. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.
    Horstmann DM; Schluederberg A; Emmons JE; Evans BK; Randolph MF; Andiman WA
    Rev Infect Dis; 1985; 7 Suppl 1():S80-5. PubMed ID: 4001740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
    Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
    Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
    Hisano M; Kato T; Inoue E; Sago H; Yamaguchi K
    Vaccine; 2016 Feb; 34(9):1208-14. PubMed ID: 26801065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rubella vaccination during an epidemic.
    Furukawa T; Miyata T; Kondo K; Kuno K; Isomura S; Takekoshi T
    JAMA; 1970 Aug; 213(6):987-90. PubMed ID: 5468562
    [No Abstract]   [Full Text] [Related]  

  • 25. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rubella antibody titres and immunization status in a family practice.
    Mills DA; Parker KR; Evans CE
    Can Med Assoc J; 1980 Mar; 122(5):549-52. PubMed ID: 7370858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Levels of antibodies against rubella and evaluation of immunity conferred by vaccination in Tucuman, Argentina].
    de Paulino I; Komaid JA; de Castagnaro NR; Raya JM
    Bol Oficina Sanit Panam; 1979 Jun; 86(6):529-33. PubMed ID: 157758
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rubella vaccination using Cendehill's live virus vaccine].
    Vivell O; Merschmann E; Lips G; Reiss G
    Arch Kinderheilkd; 1969 Sep; 179(3):259-66. PubMed ID: 5350790
    [No Abstract]   [Full Text] [Related]  

  • 30. A study of rubella immunity and resistance to infection.
    Davis WJ; Larson HE; Simsarian JP; Parkman PD; Meyer HM
    JAMA; 1971 Jan; 215(4):600-8. PubMed ID: 5107436
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rubella screening in school girls using the radial hemolysis test and their vaccination with attenuated live vaccine of the RA23/3 strain].
    Strauss J; Benes C; Macátová I
    Z Gesamte Hyg; 1988 Oct; 34(10):589-91. PubMed ID: 3201803
    [No Abstract]   [Full Text] [Related]  

  • 32. Rubella: seroepidemiology and vaccination over a ten-year period in central Italy.
    Midulla M; Assensio AM; Balducci L; Vanni O; Chiesa C
    Ann Sclavo; 1981; 23(2):127-42. PubMed ID: 7325729
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pre and post-vaccinal rubella seroepidemiology in Brittany (1971-1975). Comparative study of Cendehill and Plotkin's strains].
    Zou J; Senecal J; Morvan A; Roussey A
    Ann Pediatr (Paris); 1976 Feb; 23(2):111-8. PubMed ID: 16104238
    [No Abstract]   [Full Text] [Related]  

  • 34. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The status of rubella immunity among pregnant women in Kuwait: screening in childbearing age should be reintroduced.
    Makhseed M; Moussa MA; Ahmed MA; Abdulla N
    Acta Trop; 2001 Jan; 78(1):35-40. PubMed ID: 11164749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characterization of antirubella vaccine in an epidemiological trial].
    Popov VF; Iunasova TN; Gaĭderova LA; Aksenov LA; Averina OB; Shitikova OIu
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):41-3. PubMed ID: 15636138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiologic and preventive studies of rubella in female office workers.
    Nishihara H; Kondo H; Hashida M
    Sangyo Igaku; 1980 Jan; 22(1):18-23. PubMed ID: 7382156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a vaccination programme on the distribution of rubella antibodies in women of childbearing age.
    Hambling MH
    Lancet; 1975 May; 1(7916):1130-3. PubMed ID: 49484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
    Grillner L
    J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.